Home » Topics » BioWorld Science

BioWorld Science
RSS

Forest submits NDA for antidepressant

May 13, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

IL-18 evaluated for biological and antitumor activity

May 13, 1997

Data from U.K. phase III trial of Zacutex presented

May 13, 1997

Dura acquires two intranasal steroid products from Syntex

May 13, 1997

Preliminary phase I results for dolastatin 10 in advanced solid tumors

May 13, 1997

Animal and human pharmacokinetics of 9-NC reported

May 13, 1997

Oral toxicity of SarCNU in rats

May 13, 1997

CRF receptor antagonist from Pfizer active in animal model of depression

May 13, 1997

Preclinical and preliminary clinical studies on flavopiridol

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...